The 18-team field is set for the 2024 edition of the MLS Cup Playoffs. After setting a league record for the most points scored in a single season, Inter Miami CF was eliminated in the first round ...

在市场信心的显著表现中，Natera Inc. (NTRA)股价已达到历史新高，飙升至133.64美元。这一里程碑凸显了该公司在基因检测和诊断领域的显著增长期。过去一年，Natera的股票价值飙升，一年变化率高达193.19%。这一激增反映了投资者对公司创新产品线的乐观态度，以及其在快速增长的基因检测市场中获得更大份额的潜力。这一历史新高不仅代表了Natera股票表现的巅峰，也证明了公司持续推动其 ...

近日， 迪哲医药 ( 46.880, -0.77, -1.62%) 举办2024年第三季度业绩说明会。会上，迪哲医药管理层表示，公司高度重视并积极参与了舒沃哲®和高瑞哲®的国家医保谈判工作，具体谈判情况请关注有关部门公示或公告。 本次医保谈判我们感受到国家医保对国产原创新药的大力支持，将带动创新药行业的进一步发展，公司将继续加快全球原创新药的研发。

由安徽医科大学第一附属医院、蚌埠医学院第一附属医院、安徽省公共卫生临床中心、泰莱生物合著的学术成果《血浆游离 5-羟甲基胞嘧啶：高潜力的胃肠癌症无创检测生物标志物》被 ESMO ASIA 收录，刊载于 Annals of Oncology 中 ...

Check out some anticipated series in the video above or the slideshow gallery below, followed by the full list of new Fall season 2024 anime and where to watch them in the U.S. and their ...

Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

ECHO, a proprietary diagnostic for detection of ecDNA amplified oncogenes In September, analytical validation data was presented at the European Society for Medical Oncology (ESMO) Congress for the ...

About Aptevo Therapeutics Inc. Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies for the treatment of cancer. Aptevo is seeking ...

金秋时节逢盛会，枫叶飘扬迎嘉宾，为了加强区域交流，提高恶性肿瘤规范化诊疗水平，探讨最新治疗领域热点，2024年10月30日，由沈阳市第五人民医院主办、肿瘤内二科承办的第三届“金秋十月——沈阳肿瘤论坛”在沈阳市第五人民医院学术厅成功举办。会议邀请了中国医科大学附属第一医院肿瘤内科的国内知名专家做学术报告，线下线上数百名医务人员聆听学习。

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today reported financial results for the third quarter ...

WILMINGTON, Del., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage ...